Gracell Biotechnologies Inc (DELISTED) (GRCL:DL)
10.25
0.00 (0.00%)
USD |
NASDAQ |
Feb 22, 16:00
Gracell Biotechnologies Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -1.016M |
| June 30, 2022 | -29.22M |
| June 30, 2021 | -1.377M |
| Date | Value |
|---|---|
| September 30, 2020 | -11.81M |
| September 30, 2019 | 6.090M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-29.22M
Minimum
Jun 2022
6.090M
Maximum
Sep 2019
-7.468M
Average
-1.377M
Median
Jun 2021
Cash from Investing (Quarterly) Benchmarks
| RayzeBio inc (DELISTED) | -146.77M |
| Zai Lab Ltd | 3.292M |
| WuXi Biologics (Cayman) Inc | -- |
| Axonics Inc | 138.23M |
| I-MAB | -- |